Perrigo Co Plc (PRGO):企業の財務・戦略的SWOT分析

◆英語タイトル:Perrigo Co Plc (PRGO) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH4204FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:71
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Perrigo Co Plc (PRGO) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Perrigo Co Plc (Perrigo) is an over-the-counter consumer goods and specialty pharmaceutical company. It develops, manufactures and distributes over-the-counter products, generic and prescription pharmaceuticals, specialty pharmaceutical company, nutritional products, and infant formulas and foods. The company’s major products include analgesics, gastrointestinal, personal care and derma therapeutics, colobetasol spray, clindamycin foam, mupirocin ointment, Ketoconazole, halobetasol ointment and cream and permethrin cream. It markets products through wholesalers, retail drug, supermarket and mass merchandise chains and direct sales representatives. The company has operations in North America, Europe, Australia and other countries including Israel and China. Perrigo is headquartered in Dublin, Ireland.

Perrigo Co Plc Key Recent Developments

Feb 16,2021: Perrigo To Release Fourth Quarter And Calendar Year 2020 Financial Results On March 1, 2021
Jan 11,2021: Perrigo And Michigan State University announce partnership to advance consumer self-care innovation
Nov 04,2020: Irish high court rules Perrigo’s legitimate expectations not violated; company remains committed to vigorously challenging the notice of amended assesment
Nov 04,2020: Perrigo reports third quarter 2020 financial results
Oct 27,2020: Perrigo to build new North American corporate headquarters on “Medical Mile” in Grand Rapids, Michigan

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Perrigo Co Plc – Key Facts
Perrigo Co Plc – Key Employees
Perrigo Co Plc – Key Employee Biographies
Perrigo Co Plc – Major Products and Services
Perrigo Co Plc – History
Perrigo Co Plc – Company Statement
Perrigo Co Plc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Perrigo Co Plc – Business Description
Business Segment: Consumer Self-Care Americas
Overview
Performance
Business Segment: Consumer Self-Care International
Overview
Performance
Key Stats
Business Segment: Prescription Pharmaceuticals
Overview
Performance
Geographical Segment: All Other Countries
Target Markets
Performance
Geographical Segment: Europe
Performance
Overview
Geographical Segment: The US
Performance
R&D Overview
Perrigo Co Plc – Corporate Strategy
Perrigo Co Plc – SWOT Analysis
SWOT Analysis – Overview
Perrigo Co Plc – Strengths
Perrigo Co Plc – Weaknesses
Perrigo Co Plc – Opportunities
Perrigo Co Plc – Threats
Perrigo Co Plc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Perrigo Co Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Perrigo Co Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Perrigo Co Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 16, 2021: Perrigo To Release Fourth Quarter And Calendar Year 2020 Financial Results On March 1, 2021
Jan 11, 2021: Perrigo And Michigan State University announce partnership to advance consumer self-care innovation
Nov 04, 2020: Irish high court rules Perrigo’s legitimate expectations not violated; company remains committed to vigorously challenging the notice of amended assesment
Nov 04, 2020: Perrigo reports third quarter 2020 financial results
Oct 27, 2020: Perrigo to build new North American corporate headquarters on “Medical Mile” in Grand Rapids, Michigan
Sep 08, 2020: Perrigo announces the store brand equivalent of Voltaren Arthritis Pain is available at U.S. major retailers nationwide
Aug 05, 2020: Perrigo Company reports second quarter 2020 financial results
Aug 05, 2020: Perrigo To Release Second Quarter 2020 Financial Results On August 5, 2020
Jun 29, 2020: Sol-Gel announces agreements with Perrigo company for three new generic product candidates
Jun 19, 2020: Perrigo Company: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Perrigo Co Plc, Key Facts
Perrigo Co Plc, Key Employees
Perrigo Co Plc, Key Employee Biographies
Perrigo Co Plc, Major Products and Services
Perrigo Co Plc, History
Perrigo Co Plc, Subsidiaries
Perrigo Co Plc, Key Competitors
Perrigo Co Plc, Ratios based on current share price
Perrigo Co Plc, Annual Ratios
Perrigo Co Plc, Annual Ratios (Cont...1)
Perrigo Co Plc, Annual Ratios (Cont...2)
Perrigo Co Plc, Interim Ratios
Perrigo Co Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Perrigo Co Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Perrigo Co Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Perrigo Co Plc (PRGO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Viet Capital Securities Joint Stock Company (VCI):企業の財務・戦略的SWOT分析
    Viet Capital Securities Joint Stock Company (VCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • China Life Insurance (Overseas) Company Limited:企業の戦略・SWOT・財務情報
    China Life Insurance (Overseas) Company Limited - Strategy, SWOT and Corporate Finance Report Summary China Life Insurance (Overseas) Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Mobidiag Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Mobidiag Ltd (Mobidiag) is a biotechnology company that develops and markets products for molecular diagnosis of infectious diseases and test kits. The company's products include Novodiag, Amplidiag, and Prove-it. Its Amplidiag is a diagnostic test for high-volume screening of gastrointestin …
  • Gem Pharmaceuticals LLC-製薬・医療分野:企業M&A・提携分析
    Summary Gem Pharmaceuticals LLC (Gem Pharmaceuticals) is a clinical-stage biopharmaceutical company that develops proprietary anthracycline derivatives. The company’s pipeline products include GPX-150 for oncology, topical GPX-150 for inflammation, GPX 150 oral formulations and potency analogues pro …
  • DexCom Inc (DXCM):企業の製品パイプライン分析
    Summary Dexcom Inc (Dexcom) is a medical device company that designs, develops and commercializes continuous glucose monitoring (CGM) systems. The company’s major products include integrated CGM systems for adults and pediatric use, Dexcom G5 mobile CGM system, Dexcom G4 PLATINUM CGM system, associa …
  • Rockland Immunochemicals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Rockland Immunochemicals Inc (Rockland) is a biotechnology company that manufactures research tools for basic, applied and clinical research in functional genomics, drug discovery, gene therapy markets. The company’s products include collagen products, primary and secondary antibodies, Epi-P …
  • University of Copenhagen:製薬・医療:M&Aディール及び事業提携情報
    Summary University of Copenhagen (UCPH) is a university and research institution that offers educational and research programs and services. The university’ services include graduate and undergraduate courses, research programs, master's programs, continuing education services, online courses, inter …
  • Bonavista Energy Corp (BNP):石油・ガス:M&Aディール及び事業提携情報
    Summary Bonavista Energy Corp (Bonavista) is an intermediate energy company, which acquires, explores for, develops and produces oil and natural gas from its assets in the provinces of Alberta, British Columbia and Saskatchewan. Its core operations are concentrated in the Glauconite and Falher plays …
  • Datwyler Holding Inc (DAE):企業の財務・戦略的SWOT分析
    Datwyler Holding Inc (DAE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Minerva Biotechnologies Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Minerva Biotechnologies Corp (Minerva) is a cancer therapy and regenerative medicine company that develops immunotherapies and cancer drugs. The company offers antibody for T-cell immunotherapy, which is used in advanced breast and ovarian cancers; and humanized antibodies used for prostate …
  • Enterome Bioscience SA:企業の製品パイプライン分析2018
    Summary Enterome Bioscience SA (Enterome) is a drug development company that develops medical tests, and companion diagnostics to develop the management of microbiome-related diseases. The company develops medical tests based on its metagenotype technology platform that helps to identify microbiome- …
  • TD Ameritrade Holding Corp:企業の戦略・SWOT・財務分析
    TD Ameritrade Holding Corp - Strategy, SWOT and Corporate Finance Report Summary TD Ameritrade Holding Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Petroliam Nasional Berhad:企業の戦略・SWOT・財務情報
    Petroliam Nasional Berhad - Strategy, SWOT and Corporate Finance Report Summary Petroliam Nasional Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Etablissements Maurel & Prom SA Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Etablissements Maurel & Prom SA Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Etablissements Maurel & Prom SA Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comp …
  • Eramet:企業の戦略・SWOT・財務情報
    Eramet - Strategy, SWOT and Corporate Finance Report Summary Eramet - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • National Cancer Centre Singapore-製薬・医療分野:企業M&A・提携分析
    Summary National Cancer Centre Singapore (NCCS) is a healthcare service provider that offers research and cancer treatment services. The center offers research for cancers such as breast, gynaecology, haematology, head and neck, neuro oncology, naso pharynx cancer, paediatrics, reconstructive, hepat …
  • Paramo AS:企業の戦略的SWOT分析
    Paramo AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Align Technology Inc (ALGN):企業の財務・戦略的SWOT分析
    Align Technology Inc (ALGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Coloplast AS (COLO B):医療機器:M&Aディール及び事業提携情報
    Summary Coloplast A/S (Coloplast) is a medical device company that offers products and services for ostomy care, urology care, continence care, and skin and wound care. Its major products include ostomy bags; urisheaths; urine bags; catheters; anal irrigation systems; vaginal sling products; advance …
  • ReNeuron Group Plc (RENE):企業の財務・戦略的SWOT分析
    ReNeuron Group Plc (RENE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆